\-\ Texto\\:\\ \ \(0\)\
\-\ rapid\\ weight\\ gain\\ \\(40\\-lbs\\ in\\ one\\ year\\)\\,\\ round\\ face\\,\\ stretch\\ marks\\,\\ facial\\ flushing\\.\\ \ \(0\)\
\-\ elevated\\ \\ diurnal\\ cortisol\\,\\ elevated\\ cortisol\\ and\\ acth\\ with\\ crh\\ stimulation\\ test\\.\ \(0\)\
\-\ venous\\ sampling\\ from\\ the\\ inferior\\ petrosal\\ sinus\\ reveals\\ a\\ pituitary\\ source\\ of\\ elevated\\ acth\\ levels\\.\ \(0\)\
\-\ the\\ patient\\ underwent\\ tss\\ surgery\\ and\\ the\\ microadenoma\\ was\\ removed\\.\\ the\\ postoperative\\ period\\ was\\ uneventful\\.\\ the\\ patient\\â\\€\\™s\\ cortisols\\ levels\\ are\\ monitored\\ in\\ a\\ regular\\ basis\\.\ \(0\)\
\-\ mr\\ imaging\\ of\\ the\\ pituitary\\ demonstrates\\ a\\ 4\\,3\\ x\\ 4\\,0\\ x\\ 4\\,0\\ \\ mm\\ hypoenhancing\\ lesion\\ in\\ the\\ midline\\ of\\ the\\ anterior\\ and\\ superior\\ portion\\ of\\ the\\ anterior\\ pituitary\\ lobe\\.\\ postsurgical\\ changes\\ are\\ noted\\ in\\ the\\ sphenoid\\ sinus\\ and\\ in\\ the\\ remaining\\ pituitary\\ gland\\.\\ the\\ findings\\ are\\ compatible\\ with\\ a\\ microadenoma\\.\ \(0\)\
\-\ acth\\-secreting\\ pituitary\\ microadenoma\ \(0\)\
\-\ differential\\ diagnosis\\:\ \(3\)\
\-\ rathke\\ cleft\\ cyst\ \(0\)\
\-\ pars\\ intermedia\\ cyst\ \(2\)\
\-\ postoperative\\ changes\ \(4\)\
\-\ pituitary\\ hyperplasia\ \(1\)\
\-\ a\\ 9\\ year\\-old\\ girl\\ with\\ a\\ history\\ of\\ cushing\\â\\€\\™s\\ disease\\ presents\\ with\\ persistent\\ hypercortisolemia\\.\\ she\\ is\\ s\\/p\\ transphenoidal\\ surgery\\ \\(tss\\)\\ for\\ pituitary\\ microadenoma\\ performed\\ seven\\ months\\ ago\\,\\ with\\ a\\ negative\\ pathology\\ report\\ for\\ microadenoma\\ at\\ that\\ time\\.\ \(0\)\
\-\ this\\ is\\ a\\ typical\\ case\\ of\\ a\\ acth\\-secreting\\ pituitary\\ microadenoma\\.\\ the\\ persistence\\ of\\ symptoms\\ and\\ elevated\\ cortisols\\-acth\\ levels\\ after\\ tss\\ lead\\ to\\ further\\ work\\ up\\ which\\ revealed\\ the\\ cause\\ of\\ cushing\\â\\€\\™s\\ syndrome\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ microadenoma\\:\\ 0\\.44086828319155746\ \(0\)\
\-\ pituitary\\:\\ 0\\.4116830487038986\ \(0\)\
\-\ acth\\:\\ 0\\.36272956135902246\ \(0\)\
\-\ tss\\:\\ 0\\.26765511926334484\ \(0\)\
\-\ cortisols\\:\\ 0\\.17843674617556324\ \(0\)\
\-\ the\\:\\ 0\\.15584630854873827\ \(0\)\
\-\ elevated\\:\\ 0\\.15212776336774567\ \(0\)\
\-\ cortisol\\:\\ 0\\.14338987951136792\ \(0\)\
\-\ cushing\\:\\ 0\\.14338987951136792\ \(0\)\
\-\ levels\\:\\ 0\\.13268629585974412\ \(0\)\
\-\ postoperative\\:\\ 0\\.11587060815401153\ \(0\)\
\-\ crh\\:\\ 0\\.08921837308778162\ \(0\)\
\-\ hypercortisolemia\\:\\ 0\\.08921837308778162\ \(0\)\
\-\ of\\:\\ 0\\.08734090778032377\ \(0\)\
\-\ diurnal\\:\\ 0\\.0852529185095026\ \(0\)\
\-\ sinus\\:\\ 0\\.08062516081247886\ \(0\)\
\-\ flushing\\:\\ 0\\.08025703657550222\ \(0\)\
\-\ petrosal\\:\\ 0\\.08025703657550222\ \(0\)\
\-\ hypoenhancing\\:\\ 0\\.08025703657550222\ \(0\)\
\-\ stretch\\:\\ 0\\.07696633327084836\ \(0\)\
\-\ marks\\:\\ 0\\.07696633327084836\ \(0\)\
\-\ transphenoidal\\:\\ 0\\.0734780471985929\ \(0\)\
\-\ intermedia\\:\\ 0\\.0725459122718045\ \(0\)\
\-\ postsurgical\\:\\ 0\\.07169493975568396\ \(0\)\
\-\ sampling\\:\\ 0\\.07091212092551916\ \(0\)\
\-\ in\\:\\ 0\\.06939216503212493\ \(0\)\
\-\ changes\\:\\ 0\\.06743280071707791\ \(0\)\
\-\ gain\\:\\ 0\\.06576692289489518\ \(0\)\
\-\ persistence\\:\\ 0\\.06491595037877464\ \(0\)\
\-\ cyst\\:\\ 0\\.06436495747131837\ \(0\)\
\-\ are\\:\\ 0\\.06350789191348721\ \(0\)\
\-\ uneventful\\:\\ 0\\.06340835451702971\ \(0\)\
\-\ anterior\\:\\ 0\\.062298367521977205\ \(0\)\
\-\ stimulation\\:\\ 0\\.06150950590843399\ \(0\)\
\-\ seven\\:\\ 0\\.060167676970330805\ \(0\)\
\-\ surgery\\:\\ 0\\.059988794405929725\ \(0\)\
\-\ monitored\\:\\ 0\\.05992006844477426\ \(0\)\
\-\ basis\\:\\ 0\\.059678574339145724\ \(0\)\
\-\ and\\:\\ 0\\.057640321560804016\ \(0\)\
\-\ sphenoid\\:\\ 0\\.05611898772491757\ \(0\)\
\-\ compatible\\:\\ 0\\.055792957056112674\ \(0\)\
\-\ with\\:\\ 0\\.05462068371994396\ \(0\)\
\-\ source\\:\\ 0\\.05314107906786494\ \(0\)\
\-\ remaining\\:\\ 0\\.05301958664393755\ \(0\)\
\-\ rapid\\:\\ 0\\.051881091731676564\ \(0\)\
\-\ hyperplasia\\:\\ 0\\.050861417553900876\ \(0\)\
\-\ cleft\\:\\ 0\\.05038886117451609\ \(0\)\
\-\ face\\:\\ 0\\.050297029379092674\ \(0\)\
\-\ lead\\:\\ 0\\.04967727364507839\ \(0\)\
\-\ period\\:\\ 0\\.04877638479712477\ \(0\)\
\-\ regular\\:\\ 0\\.048169677783333455\ \(0\)\
\-\ removed\\:\\ 0\\.04739251704667696\ \(0\)\
\-\ report\\:\\ 0\\.046993277354215816\ \(0\)\
\-\ facial\\:\\ 0\\.04600204850530278\ \(0\)\
\-\ round\\:\\ 0\\.04571181906679935\ \(0\)\
\-\ work\\:\\ 0\\.0454856814924709\ \(0\)\
\-\ test\\:\\ 0\\.04537454376972922\ \(0\)\
\-\ gland\\:\\ 0\\.04531944495156386\ \(0\)\
\-\ pathology\\:\\ 0\\.043796163417881874\ \(0\)\
\-\ typical\\:\\ 0\\.043115144912798206\ \(0\)\
\-\ persistent\\:\\ 0\\.042984452352948635\ \(0\)\
\-\ reveals\\:\\ 0\\.042437470305014\ \(0\)\
\-\ midline\\:\\ 0\\.04195835339488869\ \(0\)\
\-\ ago\\:\\ 0\\.04081943031397163\ \(0\)\
\-\ mm\\:\\ 0\\.039925202467028985\ \(0\)\
\-\ portion\\:\\ 0\\.03989360303935692\ \(0\)\
\-\ venous\\:\\ 0\\.03983070883960285\ \(0\)\
\-\ girl\\:\\ 0\\.03913508239400451\ \(0\)\
\-\ weight\\:\\ 0\\.03890427488316316\ \(0\)\
\-\ was\\:\\ 0\\.03888587065047685\ \(0\)\
\-\ underwent\\:\\ 0\\.038431180534397556\ \(0\)\
\-\ cause\\:\\ 0\\.03800589551534133\ \(0\)\
\-\ inferior\\:\\ 0\\.037954012028373986\ \(0\)\
\-\ revealed\\:\\ 0\\.036580391061116685\ \(0\)\
\-\ further\\:\\ 0\\.0363361555358889\ \(0\)\
\-\ patient\\:\\ 0\\.036290566181546156\ \(0\)\
\-\ superior\\:\\ 0\\.03627059094828212\ \(0\)\
\-\ differential\\:\\ 0\\.03624883339902747\ \(0\)\
\-\ mr\\:\\ 0\\.03609787097391646\ \(0\)\
\-\ negative\\:\\ 0\\.03453844015246528\ \(0\)\
\-\ year\\:\\ 0\\.0343859951213413\ \(0\)\
\-\ for\\:\\ 0\\.03381829021744283\ \(0\)\
\-\ syndrome\\:\\ 0\\.03363288136799877\ \(0\)\
\-\ she\\:\\ 0\\.03320971989999992\ \(0\)\
\-\ time\\:\\ 0\\.03306740513463059\ \(0\)\
\-\ performed\\:\\ 0\\.03300481282910125\ \(0\)\
\-\ months\\:\\ 0\\.03247357207960686\ \(0\)\
\-\ lobe\\:\\ 0\\.032240008397760284\ \(0\)\
\-\ one\\:\\ 0\\.03194168417685376\ \(0\)\
\-\ is\\:\\ 0\\.0305562621157359\ \(0\)\
\-\ symptoms\\:\\ 0\\.030524449423172905\ \(0\)\
\-\ noted\\:\\ 0\\.029579119062375134\ \(0\)\
\-\ imaging\\:\\ 0\\.029318881597007133\ \(0\)\
\-\ diagnosis\\:\\ 0\\.028920497960772746\ \(0\)\
\-\ demonstrates\\:\\ 0\\.02802766656051718\ \(0\)\
\-\ case\\:\\ 0\\.02802766656051718\ \(0\)\
\-\ up\\:\\ 0\\.027596597559965925\ \(0\)\
\-\ findings\\:\\ 0\\.02753399094425529\ \(0\)\
\-\ after\\:\\ 0\\.02706404219859855\ \(0\)\
\-\ presents\\:\\ 0\\.026837273441030752\ \(0\)\
\-\ lesion\\:\\ 0\\.026746372779948534\ \(0\)\
\-\ which\\:\\ 0\\.02536770441448462\ \(0\)\
\-\ that\\:\\ 0\\.0242102298372916\ \(0\)\
\-\ disease\\:\\ 0\\.023418139694332204\ \(0\)\
\-\ from\\:\\ 0\\.022156930423100473\ \(0\)\
\-\ history\\:\\ 0\\.02131453611501723\ \(0\)\
\-\ at\\:\\ 0\\.02107212106072223\ \(0\)\
\-\ this\\:\\ 0\\.01917002273807224\ \(0\)\
\-\ to\\:\\ 0\\.013947080507798977\ \(0\)\
